Dalrada Corporation said it has named Dr Aboo Nasar as its new medical director of subsidiary Dalrada Health’s Sòlas Rejuvenation + Wellness center.
Dr Nasar's vast experience of more than 22 years includes being a fellowship-trained geriatrician and internal medicine physician who holds board certifications in holistic and anti-aging functional regenerative medicine through the American Academy of Anti-Aging Medicine (A4M). And he has been improving lives in the Greater San Diego Region for more than 16 years.
"With experience founding three successful medical spas in San Diego, it is a great privilege to be the Medical Director of Sòlas," said Dr Nasar in a statement. “Providing personalized, precision healthcare services with the team of talented professionals at Sòlas is a natural fit.”
READ: Dalrada partners with Lenovo and Iceotope to provide liquid-cooled rack-mounted servers with heat recovery
Sòlas’ flagship health and wellness center in San Diego hosts advanced medical-based practices, customized anti-aging & regenerative therapies, and traditional aesthetic procedures that empower people in life.
The Sòlas facility features private, tailored, state-of-the-art services where its guests can select from a wide range of therapies that currently include aesthetics, regenerative therapy; healthy habits, IV therapy lounge, hormone rebalancing, men's health & wellness, women's health & wellness, customized services, and wellness products.
Dr Nasar's ultimate passion is Holistic and Integrative Medicine, the driving force behind the anti-aging regenerative clinics he oversees. Improving his clients’ health and motivating lifestyle practices beyond pharmacotherapy is one of his specialties, with established protocols that optimize brain health.
A precision medicine market report reveals that ailments of the central nervous system (CNS) catalyzed growth in North America, where nearly 5.8 million people aged 65 years and above were diagnosed with Alzheimer's disease in 2020. By 2060, individuals diagnosed with Alzheimer's' could reach 14 million.
Overall, the North America Precision Medicine Market size surpassed US$23.2 billion in 2020 and is anticipated to grow at 11.5% CAGR from 2021 to 2027.
Precision health and wellness contrasts a one-size-fits-all approach, lending more significant consideration to an individual's genetic factors. These unique factors align with precision therapies and targeted treatments at Sòlas, optimizing care in the region.
Contact the author: patrick@proactiveinvestors.com
Follow him on Twitter @PatrickMGraham